Comparison of competing risks failure time methods and time-independent methods for assessing strain variations in vaccine protection

Statistics in Medicine

Volumn 19, Issue 22, 2000, Pages 3065-3086

  Gilbert, Peter B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL COMPUTING; PHENOTYPE; STATISTICAL ANALYSIS; STRAIN DIFFERENCE; TIME; TREATMENT FAILURE; VACCINATION;

EID: 0034736409     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20001130)19:22<3065::AID-SIM600>3.0.CO;2-D     Document Type: Article

References (39)

1. Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers
2. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types
3. Study designs for different efficacy and effectiveness aspects of vaccination
4. The efficiency of the proportions test and the logrank test for censored survival data
5. Applicability of sample size calculations based on a comparison of proportions for use with the logrank test
6. Efficiency of age-adjusted tests in animal carcinogenicity experiments
7. The analysis of failure time in the presence of competing risks
8. A mixture model for the regression analysis of competing risks data
9. Separate sample logistic discrimination
10. Regression models and life tables
11. Partial likelihood
12. A semiparametric mixture model for the analysis of competing risks data
13. General right censoring and its impact on the analysis of survival data
14. Interpretation and estimation of vaccine efficacy under heterogeneity
15. Counting process models for infectious disease data: Distinguishing exposure to infection from susceptibility
16. Applying Cox regression to competing risks
17. Independence of time and cause of failure in the multiple dependent competing risks model
18. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies
19. A class of K-sample tests for comparing the cumulative incidence of a competing risk
20. Estimates of absolute cause-specific risk in cohort studies
21. Field trial of oral cholera vaccines in Bangladesh: Results from three-year follow-up
22. Field trial of inactivated oral cholera vaccines in Bangladesh: Results from 5 years of follow-up
23. The robust inference for the Cox proportional hazards model
24. Cholera: Developments in prevention and cure
25. Feasibility of an HIV-1 vaccine efficacy trial among injecting drug users (IDUs) in Bangkok, Thailand
26. Establishment of WHO-sponsored field sites for HIV vaccine evaluation in developing countries
27. The WHO and why of HIV vaccine trials
28. Thailand weighs AIDS vaccine tests
29. Bivariate exponential distributions
30. The population biology of the interaction between HIV-1 and HIV-2: Coexistence or competitive exclusion?
31. Testing the hypothesis of proportional hazards in two populations
32. Statistical issues in the design of HIV vaccine trials
33. Estimation of vaccine efficacy in the presence of waning: Application to cholera vaccines
34. Partial residuals for the proportional hazards model
35. Proportional hazards tests and diagnostics based on weighted residuals
36. Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials